by worththewaitcharity | Oct 12, 2024 | News
This week the FDA and American Society of Clinical Oncology (ASCO) held a virtual workshop called Measuring Toxicity in Reproductive Organs During Oncology Drug Development. Mike Scherer, Worth the Wait Co-Founder, had the honor of serving as a panelist with leading...
by worththewaitcharity | Apr 25, 2024 | News
Worth the Wait Co-Founder, Mike Scherer served as a patient advocate at the Food and Drug Administration’s (FDA) mini-symposium on oncofertility. As a patient advocate speaker on this panel, featuring renowned reproductive physicians, he shared his experience...
